Summa Equity completed the acquisition of a majority stake in G-CON Manufacturing.

Summa Equity, a thematic investment company, completed the acquisition of a majority stake in G-CON Manufacturing, a US-based manufacturer of prefabricated cleanrooms used for manufacturing within the pharmaceuticals industry. Financial terms were not disclosed. "We are proud to partner with G-CON for the next, exciting chapter of its growth trajectory. We strongly believe G-CON has the potential to significantly accelerate bioprocessing production timelines, to help biopharma manufacturers get to market earlier and fully meet their capacity requirements after launch. This is a vitally important element of the healthcare value chain, ensuring that more of society has access to the right healthcare when they need it," Marika Vitia, Summa Equity Director.